Tranquis Therapeutics concludes Phase I trial of a drug targeting ALS
Clinical Trials Arena - 03-Jun-2022The drug demonstrated potential in treating neurodegenerative diseases
Join the club for FREE to access the whole archive and other member benefits.
Writer
Vishnu Priyan is a contributor who covers clinical trials and pharmaceutical developments, providing insights on emerging treatments and advancements in healthcare. His recent work includes reporting on Phase II and III trials for various therapies, including cancer treatments and vaccines.
Visit website: https://www.clinicaltrialsarena.com/author/vishnupriyan/
See alsoDetails last updated 11-Dec-2024
The drug demonstrated potential in treating neurodegenerative diseases